The immunogenicity and safety of poxvirus-based Nipah vaccines that can be used in humans and species

FHS
July 19, 2023
8:42 am

Researchers characterized the immunogenicity and safety of poxvirus-based Nipah vaccines that can be used in humans and species.

Gene therapy biotech Capsida lays off workers after expanding AbbVie pact, adding Lilly collab

Gene therapy startup Capsida Biotherapeutics said it is laying off employees, months after unveiling two Big Pharma partnerships that brought in $125 million. Capsida CEO Peter Anastasiou declined

June 29, 2023

Using a molecular testing technology for faster and comprehensive diagnosis of brain tumors

Cancer Institute Cancer Moonshot Scholars program to advance precision diagnosis of brain tumors in children.

November 4, 2024

His Death Would Not Be a Good Death

Listen and subscribe/follow on Apple and Spotify so you don’t miss the next episode. And if you like what you hear, a five-star rating goes

October 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.